Online Program Home
  My Program

All Times EDT

Legend:
* = applied session       ! = JSM meeting theme

Activity Details


65 * !
Mon, 8/9/2021, 10:00 AM - 11:50 AM Virtual
Causal Inference with Latent Variables — Invited Papers
Mental Health Statistics Section, Health Policy Statistics Section, Section on Statistics in Epidemiology, Text Analysis Interest Group
Organizer(s): Booil Jo, Stanford University School of Medicine
Chair(s): Xiao-Li Meng, Harvard University
10:05 AM A Statistical Test to Reject the Structural Interpretation of a Latent Factor Model
Tyler J VanderWeele, Harvard University; Stijn Vansteelandt, Ghent University
10:25 AM Natural Language Processing Algorithms and Their Relationship to Latent Variable Modeling
Brian Lee Egleston, Fox Chase Cancer Center; Slobodan Vucetic, Temple University
10:45 AM The Deconfounder: What Is It? What Is Its Theory? Is it Useful?
David Blei, Columbia University; Yixin Wang, U.C. Berkeley
11:05 AM Discussant: Mark Van Der Laan, University of California
11:25 AM Discussant: Kosuke Imai, Harvard University
11:45 AM Floor Discussion
 
 

90
Mon, 8/9/2021, 10:00 AM - 11:50 AM Virtual
Novel Statistical Methods for COVID Pandemic and Other Current Health Policy Issues — Contributed Speed
Health Policy Statistics Section, Text Analysis Interest Group
Chair(s): Christine Mauro, Columbia University
10:05 AM Predicting Local Demand for COVID-19 Inpatient Care with a Bayesian Susceptible-Infectious-Hospitalized-Ventilated-Recovered Model
Stella Self, University of South Carolina; Rongjie Huang, University of South Carolina; Shrujan Amin, Care Coordination Institute; Joseph Ewing, Prisma Health; Caroline Rudisill, University of South Carolina; Alexander McLain, University of South Carolina
10:10 AM COVID-19 Spatiality: Regional Surrogate Synchrony in Case Infection Rates
Samantha Robinson, University of Arkansas
10:15 AM Assessment of 12 Months of COVID-19 Outcomes: Africa and Other Continents
Obafemi Adegoke. Keshinro, University of Lagos; Kazeem Osuolale, Nigerian Institute of Medical Research; Olukemi Abiodun Keshinro, University of Lagos
10:20 AM Predictive Model for Hospitalization Due to COVID-19 Presentation
Fei Han, University of Maryland Baltimore County; Ian Stockwell , University of Maryland Baltimore County; Morgan Henderson, University of Maryland Baltimore County; Lucy Wilson, University of Maryland Baltimore County; Zach Dezman, University of Maryland, Baltimore
10:25 AM Network Autoregression of the COVID Burden
Marten Thompson, University of Minnesota
10:30 AM Adherence to Medications Used to Manage Noncommunicable Diseases During and After the COVID-19 Era Presentation
Tarek A Hassan, Viatris; Jorge Enrique Saenz, Viatris; Danute Ducinskiene, Viatris; Joseph P Cook, Viatris; Joseph S. Imperato, Viatris (Former Employee); Kelly H. Zou, Viatris
10:35 AM Boeing Confident Travel Initiative Passenger Screening Model
Lindsay Waite Jones, Boeing; Ahmad Nahhas, Boeing; Jan Irvahn, Boeing; Grace S Garden, Boeing; William Ferng, Boeing; Elizabeth Killelea, Boeing; Jason W Armstrong, Boeing; Thomas Austin, Boeing; Stephen Jones, Boeing; Joshua J Cummins, Boeing
10:40 AM Using Text Mining, Natural Language Processing, and Text Networks to Describe Content and Sentiment of Organization Emails from a Children’s Hospital
Figaro Loresto, Children's Hospital Colorado; Nadia Shive, University of Colorado; Lindsey Tarasenko, Children's Hospital Colorado
10:45 AM Fairness and Bias in COVID-19 Social Distancing Complaints: Evidence from Large-Scale Mobility Data
Constantine E. Kontokosta, New York University; Boyeong Hong, New York University; Bartosz Bonczak, New York University
10:50 AM The Impact of Lockdown Timing on COVID-19 Transmission across US Counties
Xiaolin Huang, University of Victoria; Xiaojian Shao, National Research Council Canada; Xing Li, University of Saskatchewan; Yushan Hu, University of Victoria; Don D. Sin, St Paul’s Hospital and University of British Columbia; Xuekui Zhang, University of Victoria
11:00 AM Estimating the Association Between COVID-19 Vaccine Coverage and Deaths in Connecticut
Samantha G Dean, Department of Biostatistics, Yale School of Public Health; Olga Morozova, Program in Public Health, Stony Brook University; Matthew Cartter, Connecticut Department of Health; Amanda Durante, Connecticut Department of Health; Forrest W. Crawford, Yale University
11:05 AM A New Statistical Modeling Approach for Survival Analysis of Cancer Patients: Multiple Myeloma Cancer
Lohuwa Mamudu, University of South Florida; Chris P. Tsokos, University of South Florida
11:10 AM Fair Regression for Multiple Undercompensated Groups
Samson Mataraso, Stanford University; Anna Zink, Harvard University; Sherri Rose, Stanford University
11:15 AM Propensity Score Matched Cohort for Benchmarking Hospital Mortality Using Indirect Method of Standardization
Brenda Vincent, North Dakota State University ; Bong-Jin Choi, North Dakota State University
11:20 AM Assessing Classification Accuracy of Hospitals' Performance on Discrete Outcome
Zhou Lan, Yale School of Medicine; Zhenqiu Lin, Yale New Haven Hospital; Haiqun Lin, Rutgers University; Shu-Xia Li, Yale New Haven Hospital; Chengan Du, Yale School of Medicine
11:25 AM Statistical Modeling of Longitudinal Medical Cost Trajectory
Shikun Wang, The University of Texas MD Anderson Cancer Center; Jing Ning, The University of Texas MD Anderson Cancer Center; Ya-Chen Tina Shih, The University of Texas MD Anderson Cancer Center; Yu Shen, The University of Texas MD Anderson Cancer Center; Liang Li, The University of Texas MD Anderson Cancer Center; Ying Xu, The University of Texas MD Anderson Cancer Center
11:30 AM Sequential Pattern Mining of Electronic Health Record for Early Diagnosis of Amyotrophic Lateral Sclerosis
Ying Liu, Princeton Pharmatech; Cindy Liang, Texas Academy of Mathematics and Science; Lily Sun, Stanford OHS; Jeffery Zhang, Princeton Pharmatech
11:35 AM Historical Aspects of Statistical Approach to Dynamic of Neural Networks
Michael Fundator, Affl; National Academy of Sciences
11:40 AM Does Health Value and Practice Make Difference on Racial and Ethnic Disparities in Health Outcomes
Shuying Sha, Scho
11:45 AM Analysis of the Yearly Transition Function in Measles Disease Modeling
Carlo Stefan Davila-Payan, Centers for Disease Control and Prevention; Andrew Hill, Centers for Disease Control and Prevention; Xi Li, Centers for Disease Control and Prevention; Michael Lynch, Centers for Disease Control and Prevention; Sarah W. Pallas, Centers for Disease Control and Prevention
 
 

Register 96
Mon, 8/9/2021, 12:00 PM - 1:20 PM Virtual
Health Policy Statistics Section P.M. Roundtable Discussion (Added Fee) — Roundtables PM Roundtable Discussion
Health Policy Statistics Section
ML05: Anti-Racism in the Ivory Tower
Laura Hatfield, Harvard Medicial School
ML06: So Many Choices: Selecting Methods to Adjust for Observed Confounders
Luke J Keele, University of Pennsylvania
 
 

128 *
Mon, 8/9/2021, 1:30 PM - 3:20 PM Virtual
New Methods and Diagnostics for Propensity Score Matching — Topic-Contributed Papers
Health Policy Statistics Section, Biometrics Section, ENAR
Organizer(s): Ben B. Hansen, University of Michigan
Chair(s): Ben B. Hansen, University of Michigan
1:35 PM Evaluating and Improving a Matched Comparison of Antidepressants and Bone Density
Ruoqi Yu, University of Pennsylvania
1:55 PM Accounting for Inexact Matching via Model-Weighted Randomization Inference and Partially Randomized Design
Samuel D. Pimentel, University of California, Berkeley
2:15 PM Fast Algorithms for Propensity Score Matching Presentation
Pavel Ruzankin, Novosibirsk State University; Anton S. Tarasenko, Novosibirsk State University
2:35 PM Full Matching with More Precise Set Size Constraints Presentation
Mark Fredrickson, University of Michigan, Ann Arbor; Ben B. Hansen, University of Michigan
2:55 PM Discussant: Thomas E. Love, Case Western Reserve University School of Medicine
3:15 PM Floor Discussion
 
 

220786
Mon, 8/9/2021, 5:30 PM - 7:00 PM
Health Policy Statistics Section Business Meeting and Mixer — Other Cmte/Business
Health Policy Statistics Section, Mental Health Statistics Section
Chair(s): Mousumi Banerjee, University of Michigan
Monday August 9, 2021, 5:30 pm - 7:00 pm Eastern

Click the link to join the HPSS and MHS joint mixer: https://txstate.zoom.us/my/JSM2021Mixer
 
 

142 * !
Tue, 8/10/2021, 10:00 AM - 11:50 AM Virtual
Recent Development in Computational Biology and Bioinformatics — Invited Papers
Section on Statistics in Genomics and Genetics, Section on Statistics in Epidemiology, Health Policy Statistics Section
Organizer(s): Wenxuan Zhong, University of Georgia
Chair(s): Wenxuan Zhong, University of Georgia
10:05 AM Deep Generative Modeling of Single Cell Chromatin Conformation Capture Data
Sunduz Keles, University of Wisconsin, Madison; Siqi Shen, University of Wisconsin; Ye Zheng, Fred Hutchinson Cancer Research Center
10:30 AM Analyzing Genomic Data Using Neural Networks
Wei Sun, Fred Hutchinson Cancer Research Center
10:55 AM Cell-to-Cell Trajectories and Pathway Construction for Time-Course Single Cell RNA-Seq Data
Ping Ma, University of Georgia
11:20 AM A Statistical Framework to Identify Cell Types Whose Genetically Regulated Proportions Are Associated with Complex Diseases
Wei Liu, Yale University ; Wenxuan Deng, Yale University; Ming Chen, Yale University; Zihan Dong, Yale University; Biqing Zhu, Yale University; Zhaolong Yu, Yale University; Daiwei Tang, Yale University; Hongyu Zhao, Yale University
11:45 AM Floor Discussion
 
 

148 * !
Tue, 8/10/2021, 10:00 AM - 11:50 AM Virtual
Considerations in Clinical Trial Endpoints’ Selection — Invited Papers
Biopharmaceutical Section, Health Policy Statistics Section, Biometrics Section, Caucus for Women in Statistics
Organizer(s): Freda Cooner, Amgen
Chair(s): Laura Fernandes, FDA
10:05 AM Treatment-Free Survival and Depth of Response as Novel Endpoints of Immuno-Oncology (IO)-Based Therapy for Metastatic Renal Cell Carcinoma (MRCC) Presentation
Meredith M Regan, Dana-Farber Cancer Institute; Laura Fernandes, FDA
10:30 AM Handling Missing Data Through Combining of Endpoints
Jitendra Ganju, Ganju Clinical Trials, LLC; Ron Yu, Gilead Sciences
10:55 AM Win Statistics: Impact of Follow-up Time and Unbiased Estimators of Treatment Effect in the Presence of Censoring
Gaohong Dong, BeiGene; Victoria Chang, BeiGene; Bo Huang, Pfizer Inc.; James Song, BeiGene; Duolao Wang, Liverpool School of Tropical Medicine, UK; Lu Mao, University of Wisconsin; Jiuzhou Wang, ImmunoGen Inc.; Johan Verbeeck, University Hasselt, Belgium ; Margaret Gamalo-Siebers, Pfizer Inc.; David C. Hoaglin, University of Massachusetts Medical School
11:20 AM How to Measure the Treatment Effect in COVID-19 Clinical Studies?
Lu Tian, Stanford University ; LJ Wei, Harvard University; Zachary McCaw, Google Inc
11:45 AM Floor Discussion
 
 

156 !
Tue, 8/10/2021, 10:00 AM - 11:50 AM Virtual
Health Policy Statistics Section Student Paper Award — Topic-Contributed Papers
Health Policy Statistics Section
Organizer(s): Hui Xie, University of Illinois
Chair(s): Mousumi Banerjee, University of Michigan
10:05 AM A Conditional Random Forest Approach to Estimating the Most Cost-Effective Individualized Treatment Rule
YIZHE XU, University of Utah; Tom Greene, University of Utah; Adam Bress, University of Utah; Brandon Bellows, Columbia University Medical Center; William Weintraub, MedStar Health Research Institute ; Andrew Moran , Columbia University Medical Center; Jincheng Shen, University of Utah
10:25 AM Effectiveness of Localized Lockdowns in the COVID-19 Pandemic Presentation
Yige Li, Department of Biostatistics, Harvard T.H. Chan School of Public Health; Eduardo A. Undurraga, Escuela de Gobierno, Pontificia Universidad Católica de Chile; Jose Zubizarreta, Harvard University
10:45 AM Stratified Proportional Hazards Models for Clustered Interval-Censored Data with Time-Dependent Covariates
Kaitlyn Cook, Harvard University; Wenbin Lu, North Carolina State University; Rui Wang, Harvard Pilgrim Health Care Institute
11:05 AM Improved Matching via Augmented Propensity Score Estimation
Ernesto Ulloa, Department of Biostatistics, University of Washington; Marco Carone, University of Washington; Alex Luedtke, University of Washington
11:25 AM Social Distancing and COVID-19: Randomization Inference for a Structured Dose-Response Relationship
Bo Zhang, University of Pennsylvania; Siyu Heng, University of Pennsylvania; Ting Ye, University of Pennsylvania; Dylan S. Small, University of Pennsylvania
11:45 AM Floor Discussion
 
 

Register 173
Tue, 8/10/2021, 12:00 PM - 1:20 PM Virtual
Health Policy Statistics Section P.M. Roundtable Discussion (Added Fee) — Roundtables PM Roundtable Discussion
Health Policy Statistics Section
TL05: Innovative Uses of Electronic Healthcare Records to Construct Family Health Histories for Chronic Disease Risk Prediction
Lisa Lix, University of Manitoba
TL06: Selling the AI/ML Narrative Ethically
Frank Yoon, IBM Watson Health
 
 

191 * !
Tue, 8/10/2021, 1:30 PM - 3:20 PM Virtual
Statistical Research in Rapid Response to COVID-19 Pandemic: Forecasts, Risk Factors, Therapeutics, and Vaccine Trials — Invited Papers
Health Policy Statistics Section, ENAR, Biometrics Section
Organizer(s): Yuanjia Wang, Columbia University
Chair(s): Shanghong Xie , Columbia Unviersity
1:35 PM COVID-19 Forecasts and Scenarios for the United States
Bobby Reiner, University of Washington
1:55 PM A Hierarchical Epidemic Model to Estimate the Time-Varying Reproduction Numbers and Prevalence of COVID-19 Infections Accounting for Under-Reporting and Delayed Reporting of Cases
Rounak Dey, Harvard T.H. Chan School of Public Health; Haoyu Zhang, Harvard T.H. Chan School of Public Health; Corbin Quick, Harvard T.H. Chan School of Public Health; Xihong Lin, Harvard T.H. Chan School of Public Health
2:15 PM Dynamic Risk Assessment of COVID-19 Hospitalization from Electronic Health Records (EHRs)
Yuanjia Wang, Columbia University
2:35 PM Statistical Aspects of COVID-19 Vaccine Trials
Dean Follmann, NIH
2:55 PM Discussant: Donglin Zeng, UNC Chapel Hill
3:15 PM Floor Discussion
 
 

247
Wed, 8/11/2021, 10:00 AM - 11:50 AM Virtual
Causal Inference and Statistical Learning of Intervention and Policy Effects — Contributed Speed
Health Policy Statistics Section
Chair(s): Yifan Cui, National University of Singapore
10:05 AM A Bayesian Nonparametric Approach for Causal Inference with Missing Covariates Presentation
Huaiyu Zang, Cincinnati Children's Hospital Medical Center; Hang Kim, University of Cincinnati; Bin Huang, Cincinnati Children's Hospital Medical Center
10:10 AM Assignment-Control Plots: A Visualization Tool for Observational Studies
Michael Baiocchi, Stanford University; Rachael Caelie Aikens, Stanford University
10:15 AM How Did the Timothy’s Law Impact Hospitalization Among Mental Patients in New York State? A Causal Approach to a Mental Disparity Policy
Mingfei Li, Bentley University; Victor S.Y. Lo, Fidelity Investments; Piaomu Liu, Bentley University; Eric Smith, Center for Healthcare Organization and Implementation Research, VA Bedford Hospital
10:20 AM Evaluating Effects of ECHO Training of Care Providers for Opioid Use Disorder: A Framework of Observational Studies Utilizing Medical Claims Data and Interrupted Time Series Models Presentation
Jessica Reno, University of New Mexico; Yiliang Zhu, University of New Mexico; Laura Tomedi, University of New Mexico; Julio Facelli, University of Utah; Miriam Komaromy, Boston Medical Center; Alica Ventura, Boston Medical Center; Julie Donohue, University of Pittsburgh; Marisa Domino, University of North Carolina
10:25 AM Causal Framework for Individualized Treatment Evaluation Using Multivariate Generalized Mixed Effect Models with Longitudinal Data
Yizhen Xu, Johns Hopkins University; Akihiko Nishimura, Johns Hopkins Bloomberg School of Public Health; Jisoo Kim, Johns Hopkins University; Brian Garibaldi, Johns Hopkins University; Ami Shah, Johns Hopkins University; Scott Zeger, Johns Hopkins University
10:30 AM Statistical Methods for Testing the Impact of State-Level Marijuana Laws on Substance Use Using Published Prevalence Estimates
Christine Mauro, Columbia University; Amy Pitts, Columbia University
10:35 AM Identifying Optimally Cost-Effective and Interpretable Dynamic Treatment Regimes
Nicholas Illenberger, University of Pennsylvania; Nandita Mitra, University of Pennsylvania; Andrew Justin Spieker, Vanderbilt University Medical Center
10:40 AM Estimating the Impact of an Unsanctioned Safe Consumption Site in the United States: An Application of the Covariate Balancing Propensity Score
Erica Nicole Browne, RTI International; Barrot H Lambdin, RTI International; Peter J. Davidson, University of California San Diego, Department of Medicine; Lynn H Wenger, RTI International; Alex H Kral, RTI International
10:45 AM Causal effects estimation of multiple treatments using observational data
Yingying Lu, University of Arizona; Lingling An, University of Arizona
10:50 AM A Propensity-Matched Study of Obesity and Diabetes Risk: A COVID-19 Perspective
Claire Nurse, SUNY Downstate School of Public Health; Janet Rosenbaum, SUNY Downstate School of Public Health
11:00 AM Bayesian Multivariate Network Meta-Analysis Model for the Difference in Restricted Mean Survival Times
Xiaoyu Tang, Department of Biostatistics, Boston Uiversity School of Public Health; Ludovic Trinquart, Department of Biostatistics, Boston University School of Public Health
11:05 AM Bridging Randomized Controlled Trials and Single-Arm Trials Using Commensurate Priors in Arm-Based Network Meta-Analysis
Zhenxun Wang, University of Minnesota Twin Cities; Lifeng Lin, Florida State University; Thomas Murray, Division of Biostatistics, University of Minnesota; James Hodges, University of Minnesota Twin Cities; Haitao Chu, University of Minnesota Twin Cities
11:10 AM Network Meta-Analysis of Time-to-Event Data with Cox Regression Using Individual Patient-Level Data
Kaiyuan Hua, Duke University, Department of Biostatistics and Bioinformatics; Daniel Wojdyla, Duke Clinical Research Institute; Anthony Carnicelli, Duke Clinical Research Institute; Christopher Bull Granger, Duke Clinical Research Institute; Hwanhee Hong, Duke University, Department of Biostatistics and Bioinformatics
11:15 AM A Weighted Method for Extending Inferences from a Collection of Randomized Controlled Trials
Nicole Schnitzler, Ohio State University ; Eloise Kaizar, Ohio State University
11:20 AM Adjusting for Stratification Variables in Cluster-Randomized Trials
Patrick Gravelle, Brown University; Roee Gutman, Brown University
11:25 AM Identification and Estimation of Causal Effects by Cross-Temporal Design
Yi Cao, Brown University; Roee Gutman, Brown University
11:30 AM Enhancing Patient-Level Clinical Trial Data with Medical Expenditure Panel Survey Data: Quick Start Guide to the Enhanced Data Sets
Jennifer Unangst, RTI International; Steven B. Cohen, RTI; Feng Yu, RTI International
11:35 AM The Impact of Continuity Corrections on Rare-Event Meta-Analysis
Brinley Zabriskie, Brigham Young University; Nolan Cole, Brigham Young University; Jake Baldauf, Brigham Young University
11:40 AM Signal or Noise: Recanting in HIV Prevention Trials
Janet Rosenbaum, SUNY Downstate School of Public Health
 
 

248
Wed, 8/11/2021, 12:00 PM - 1:20 PM Virtual
Health Policy Statistics Section Lunchtime Speaker — Roundtables Speaker with Lunch
Health Policy Statistics Section
Chair(s): Mousumi Banerjee, University of Michigan
12:05 PM A Seat at the Table: The Key Role of Statistics and Data Science in the COVID-19 Pandemic
Jeffrey S. Morris, University of Pennsylvania Perelman School of Medicine
 
 

Register 250
Wed, 8/11/2021, 12:00 PM - 1:20 PM Virtual
Health Policy Statistics Section P.M. Roundtable Discussion (Added Fee) — Roundtables PM Roundtable Discussion
Health Policy Statistics Section
WL04: Health Policy Statistics: Stories of Adventure, Intrigue, and Speaking Truth to Power
Ruth Etzioni, Fred Hutchinson Cancer Research Center
 
 

262 * !
Wed, 8/11/2021, 1:30 PM - 3:20 PM Virtual
Emerging Statistical Theory and Methods in Deep Learning — Invited Papers
Section for Statistical Programmers and Analysts, Section on Statistical Learning and Data Science, Health Policy Statistics Section
Organizer(s): Ping Ma, University of Georgia
Chair(s): Ping Ma, University of Georgia
1:35 PM Probabilistic Connection Importance Inference and Lossless Compression of Deep Neural Networks
Xin (Shayne) Xing, Virginia Tech
2:05 PM Causal Inference via Artificial Neural Networks: From Prediction to Causation
Shujie Ma, University of California, Riverside; Xiaohong Chen, Yale University; Ying Liu, University of California, Riverside; Zheng Zhang, Renmin University of China
2:35 PM Sufficient Dimension Reduction for Classification Using Principal Optimal Transport Direction
Cheng Meng, Institute of Statistics and Big Data, Renmin University of China; Jun Yu, School of Mathematics and Statistics, Beijing Institute of Technology; Jingyi Zhang, Center for Statistical Science, Tsinghua University; Ping Ma, University of Georgia; Wenxuan Zhong, University of Georgia
3:15 PM Floor Discussion
 
 

278 * !
Wed, 8/11/2021, 1:30 PM - 3:20 PM Virtual
Innovative Methods for Predicting Public Health Outcomes and Informing Policy — Topic-Contributed Papers
Section on Statistics in Epidemiology, ENAR, Health Policy Statistics Section
Organizer(s): Ashley Buchanan, College of Pharmacy, University of Rhode Island
Chair(s): Anarina Murillo, Brown University
1:35 PM Spillover Effects of Pre-Exposure Prophylaxis Delivery for HIV Prevention: Evaluating the Importance of Effect Modification using an Agent-Based Model
Ashley Buchanan, College of Pharmacy, University of Rhode Island; Carolyn Park, Brown School of Public Health; Sam Bessey, Brown School of Public Health; William Goedel, Brown School of Public Health; Eleanor Murray, Boston University; Samuel Friedman, Department of Population Health, NYU Grossman School of Medicine; M. Elizabeth Halloran, Public Health Sciences Division, Fred Hutch; Natallia Katenka, Department of Computer Science and Statistics, University of Rhode Island; Brandon DL Marshall, Brown School of Public Health
1:55 PM Multilevel Network Models for Evaluation of Network-Informed HIV Prevention Interventions
Nicole Bohme Carnegie, Montana State University
2:15 PM Novel Application of a Multistate Model to Investigate the Opioid Use Disorder Care Cascade in Rhode Island
Hilary Aroke, University of Rhode Island; Ashley Buchanan, College of Pharmacy, University of Rhode Island; Anarina Murillo, Brown University; Tianyu Sun, University of Rhode Island; Jeffrey Bratberg, University of Rhode Island; Stephen Kogut, University of Rhode Island; Brandon DL Marshall, Brown School of Public Health; Joseph Hogan, Brown University
2:35 PM Cardiovascular Health Inequities: Innovative Methods Coupled with Diverse Observational Cohorts Equals a Recipe for Evidence-Based Policies
Loni Tabb, Drexel Univerisity
2:55 PM Discussant: Joseph Hogan, Brown University
3:15 PM Floor Discussion
 
 

284 * !
Wed, 8/11/2021, 1:30 PM - 3:20 PM Virtual
Learning Individualized/Sub-Group Treatment Rules in Complex Settings — Topic-Contributed Papers
Health Policy Statistics Section, Social Statistics Section, Section on Statistics in Epidemiology
Organizer(s): Rahul Ladhania, University of Michigan
Chair(s): Lyle Ungar, University of Pennsylvania
1:35 PM Personalizing Treatment Assignment Rules in Large Multi-Arm Experimental Settings
Rahul Ladhania, University of Michigan; Lyle Ungar, University of Pennsylvania
1:55 PM Automatic Regression Discontinuity Discovery Using Tree-Based Partitioning
Tony Liu, University of Pennsylvania; Rahul Ladhania, University of Michigan; Lyle Ungar, University of Pennsylvania; Konrad Kording, University of Pennsylvania
2:15 PM Discovering Anomalous Patterns of Care Using Health Insurance Claims
Sriram Somanchi, University of Notre Dame; Edward McFowland III, University of Minnesota; Daniel B Neill, New York University
2:35 PM Instrumental Variable Approaches to Individualized Decision Making Under Endogeneity
Yifan Cui, National University of Singapore
2:55 PM Learning for Long-Term Outcomes
Jeremy Yang, MIT; Dean Eckles, Massachusetts Institute of Technology; Paramveer Dhillon, University of Michigan; Sinan Aral, MIT
3:15 PM Floor Discussion
 
 

291 * !
Wed, 8/11/2021, 3:30 PM - 5:20 PM Virtual
Using EHRs to Run Pragmatic Trials: Opportunities and Challenges — Invited Papers
Health Policy Statistics Section, Society for Medical Decision Making, Academy for Health Services Research and Health Policy
Organizer(s): Lili Zhao, University of Michigan
Chair(s): Lili Zhao, University of Michigan
3:35 PM The Perils and Pitfalls of Pragmatic Trial Design
Christopher Lindsell, Vanderbilt University Medical Center
4:00 PM Randomized Pragmatic Clinical Trials Utilizing RWD: Myths and Realities Presentation
Frank W. Rockhold, Duke University School of Medicine
4:25 PM Learning While Treating: Health System-Based Pragmatic Trials to Learn Effective Interventions
Benjamin A Goldstein, Duke University
4:50 PM Patient Recruitment and Efficient Estimation Leveraging Electronic Health Records
Guanghao Zhang, University of Michigan; Lauren Beesley, Department of Biostatistics, University of Michigan; Bhramar Mukherjee, University of Michigan; Xu Shi, Department of Biostatistics, University of Michigan
5:15 PM Floor Discussion
 
 

325 * !
Thu, 8/12/2021, 10:00 AM - 11:50 AM Virtual
Machine Learning Methods for Better-Informed Decision-Making in Heath Care — Invited Papers
Health Policy Statistics Section, Section on Statistics in Epidemiology, Biometrics Section
Organizer(s): Jiwei Zhao, University of Wisconsin-Madison
Chair(s): Gen Li, University of Michigan
10:05 AM Multiple Instance Learning with Distributional Data: Application to Early-Stage Breast Cancer Diagnosis
Menggang Yu, University of Wisconsin
10:30 AM High-Dimensional Directional Brain Network Analysis for Focal Epileptic Seizures
Tingting Zhang, University of Pittsburgh
10:55 AM Predicting the Number of Future Events for Time-to-Event Data
Qinglong Tian, Iowa State University
11:20 AM Balance Competing Outcomes in Dynamic Treatment Regime Estimation
Michael Kosorok, University of North Carolina at Chapel Hill; Siyeon Kim, University of North Carolina
11:45 AM Floor Discussion
 
 

360 * !
Thu, 8/12/2021, 12:00 PM - 1:50 PM Virtual
Advances and Challenges in Recent Diagnostic Research — Invited Papers
Section on Medical Devices and Diagnostics, Biometrics Section, Health Policy Statistics Section, Caucus for Women in Statistics
Organizer(s): Zheyu Wang, Johns Hopkins
Chair(s): Yuxin Zhu, Johns Hopkins
12:05 PM Assessing Misdiagnosis-Related Harm with Electronic Medical Records
Yuxin Zhu, Johns Hopkins; Zheyu Wang, Johns Hopkins
12:30 PM Strategies for Validating Biomarkers Using Data from a Reference Set
Ying Huang, Fred Hutchinson Cancer Research Center; Lu Wang, Peking University; Ziding Feng, Fred Hutchinson Cancer Research Center
12:55 PM Longitudinal Modeling of Disease Progression Biomarkers in the Latent Disease Timescale: Example of Alzheimer’s Disease and Related Disorders
Cécile Proust-Lima, University of Bordeaux; Jérémie Lespinasse, Univ. Bordeaux, INSERM, BPH; Carole Dufouil, Univ. Bordeaux, INSERM, BPH
1:20 PM Correcting for Imperfect Gold Standard and Verification Bias in Estimating Accuracy of Diagnostic Tests: An Application on COVID-19 Diagnosis with CT and RT-PCR
Xiao-Hua Zhou, Peking University
1:45 PM Floor Discussion
 
 

374 * !
Thu, 8/12/2021, 12:00 PM - 1:50 PM Virtual
Statistical Approaches for Evidence Integration and Considerations to Communication in Product Labeling — Topic-Contributed Papers
Biopharmaceutical Section, Health Policy Statistics Section, Biometrics Section
Organizer(s): Jennifer Clark, FDA
Chair(s): Ross Bray, Eli Lilly and Company
12:05 PM Unified Framework of Meta-Analysis, Composite Likelihoods, and Bayesian Methods for Evidence Integration in Pediatric Extrapolation Development Archetypes
Margaret Gamalo-Siebers, Pfizer Inc.; Junjing Lin, Takeda Pharmaceuticals
12:25 PM Using Robust Bayesian Priors to Borrow Information from Historical Adult Trials for a Clinical Trial in Pediatric Multiple Sclerosis
Marius Thomas, Novartis; David Ohlssen, Novartis; Heinz Schmidli, Novartis; Dieter Haering, Novartis
12:45 PM Extrapolating Adult Efficacy Data to Pediatric Populations via Bayesian Hierarchical Models
Benjamin R Saville, Berry Consultants; Kert Viele, Berry Consultants
1:05 PM Partial Extrapolating of Efficacy from Adult to Pediatrics: A Case Study in Systemic Lupus Erythematosus
Juan Jose Abellan, GSK
1:25 PM Discussant: James Travis, FDA
1:45 PM Floor Discussion
 
 

393 * !
Thu, 8/12/2021, 2:00 PM - 3:50 PM Virtual
From Health Disparity to Health Fairness: Stories Told, Lessons Learned, and Science Forward — Invited Papers
Academy for Health Services Research and Health Policy, Health Policy Statistics Section, Society for Medical Decision Making
Organizer(s): Chen-Pin Wang, University of Texas Health Science Center San Antonio
Chair(s): Chen-Pin Wang, University of Texas Health Science Center San Antonio
2:05 PM Flawed Approaches to Reducing Disparities in Medical Guidelines: The Importance of Using Prediction Models of Risk and Benefit
Hormuzd Katki, National Cancer Institute; Li C Cheung, US National Cancer Institute; Rebecca Landy, US National Cancer Institute; Corey Young, Morehouse School of Medicine
2:25 PM Evaluating Preventive Care to Reduce Dental Disparities in Children with Electronic Health Record (EHR)
Jing Cheng, University of California, San Francisco
2:45 PM New Advances for Fairness in Plan Payment Risk Adjustment
Anna Zink, Harvard University; Sherri Rose, Stanford University
3:05 PM Discussant: Elizabeth L. Ogburn, Johns Hopkins University
3:25 PM Discussant: Trang Nguyen, JHU
3:45 PM Floor Discussion
 
 

394 * !
Thu, 8/12/2021, 2:00 PM - 3:50 PM Virtual
Population Diversity Considerations in Clinical Trials — Invited Papers
Health Policy Statistics Section, Social Statistics Section, Biopharmaceutical Section, Caucus for Women in Statistics
Organizer(s): Freda Cooner, Amgen
Chair(s): Freda Cooner, Amgen
2:05 PM Digitizing Clinical Trials to Enhance Diversity
Demissie Alemayehu, Pfizer; Kannan Natarajan, Pfizer Inc.; Satrajit Roychoudhury, Pfizer Inc.
2:25 PM Diversity and Inclusion in Clinical Trials
Rajaa Nahra, AstraZeneca; Claudia Cabrera, AstraZeneca
2:45 PM Enrollment Disparities by Demographic Subgroups in Oncology Clinical Trials Submitted to the US FDA
Laura Fernandes, FDA
3:05 PM Leveraging Real-World Evidence to Increase Diversity of Populations in Clinical Trials
Cody Chiuzan, Columbia University
3:25 PM Discussant: Ruthanna Davi, Medidata Solutions
3:45 PM Floor Discussion